List of insiders holdings for CRISPR Therapeutics AG:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GLAXOSMITHKLINE PLC 10% Owner | 2020-07-10 17:26:33 | 3,310,627 0 | 3,310,627 | Form 13D |
| BAYER AKTIENGESELLSCHAFT Bayer Global Investments B.V. 10% Owner | 2020-02-04 16:19:06 | 2,954,775 0 | 2,954,775 | Form 13D |
| CELGENE CORP 10% Owner | 2018-02-08 16:25:56 | 2,800,772 0 | 2,800,772 | Form 13D |
| Vertex Pharmaceuticals (Europe) Ltd VERTEX PHARMACEUTICALS INC 10% Owner | 2020-02-13 16:05:28 | 2,690,470 0 | 2,690,470 | Form 13G |
| Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures IV LLC Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner | 2021-02-16 07:33:52 | 1,344,010 0 | 1,344,010 | Form 13D |
| Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner | 2021-02-16 07:33:52 | 1,344,010 0 | 1,344,010 | Form 13D |
| EMSTER KURT VON Director | 2019-01-18 16:32:23 | 0 1,171,268 | 1,171,268 | Form 4/A |
| Lundberg Sven Ante Chief Scientific Officer | 2017-02-10 14:16:28 | 505,217 505,617 | 1,010,834 | Form 4 |
| Hadley Harbor Master Investors (Cayman) L.P. 10% Owner | 2016-10-24 14:58:09 | 744,380 0 | 744,380 | Form 4 |
| Novak Rodger President | 2021-07-01 17:43:55 | 573,007 0 | 573,007 | Form 4 |
| Kulkarni Samarth Chief Executive Officer | 2025-03-24 17:35:09 | 254,147 85,622 | 339,769 | Form 4 |
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-08-10 20:00:31 | 132,891 0 | 132,891 | Form 4 |
| Versant Venture Capital V L.P. Versant Ventures V LLC Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP 10% Owner | 2018-04-26 16:44:03 | 0 115,645 | 115,645 | Form 4 |
| KASINGER JAMES R. General Counsel and Secretary | 2025-03-24 17:35:04 | 100,479 0 | 100,479 | Form 4 |
| Subramanian Kala See Remarks | 2017-06-19 16:05:33 | 85,000 0 | 85,000 | Form 4 |
| Patel Naimish Chief Medical Officer | 2025-03-18 17:35:08 | 79,167 0 | 79,167 | Form 4 |
| Dylan-Hyde Tyler Chief Legal Officer | 2018-01-18 17:38:36 | 67,104 0 | 67,104 | Form 4 |
| Ho Tony W Executive VP, Head of R&D | 2021-12-07 20:00:19 | 65,697 0 | 65,697 | Form 4 |
| CAGNONI PABLO J Director | 2019-11-21 16:07:43 | 63,833 0 | 63,833 | Form 4 |
| Prasad Raju Chief Financial Officer | 2025-03-24 17:35:06 | 35,517 0 | 35,517 | Form 4 |
| Woiwode Thomas Director | 2018-06-15 21:39:45 | 0 30,000 | 30,000 | Form 4 |
| Bruno Julianne Chief Operating Officer | 2025-03-24 17:35:07 | 21,794 7,088 | 28,882 | Form 4 |
| Rommel Christian Director | 2024-05-31 16:15:05 | 26,000 0 | 26,000 | Form 4 |
| Morrow Phuong Khanh Chief Medical Officer | 2023-10-17 17:52:27 | 16,667 0 | 16,667 | Form 4 |
| Smith Brendan Chief Financial Officer | 2023-02-22 17:41:41 | 16,547 0 | 16,547 | Form 4 |
| COLES N ANTHONY Director | 2017-06-02 16:30:19 | 15,000 0 | 15,000 | Form 4 |
| Mahatme Sandesh Director | 2024-05-31 16:15:06 | 13,000 0 | 13,000 | Form 4 |
| Fardis Maria Director | 2024-05-31 16:15:06 | 13,000 0 | 13,000 | Form 4 |
| Behbahani Ali Director | 2024-05-31 16:50:04 | 13,000 0 | 13,000 | Form 4 |
| George Simeon Director | 2024-05-31 16:50:29 | 13,000 0 | 13,000 | Form 4 |
| High Katherine A Director | 2024-05-31 16:15:04 | 13,000 0 | 13,000 | Form 4 |
| Treco Douglas A Director | 2024-05-31 16:15:03 | 13,000 0 | 13,000 | Form 4 |
| Fleming Harold Edward Director | 2024-05-31 16:15:03 | 13,000 0 | 13,000 | Form 4 |
| Klein Lawrence Otto CBO & COO | 2022-08-18 17:36:02 | 12,500 0 | 12,500 | Form 4 |
| Bolzon Bradley J PhD Director | 2022-06-10 17:35:09 | 12,000 0 | 12,000 | Form 4 |
| Greene John Director | 2025-02-28 17:35:05 | 7,000 0 | 7,000 | Form 4 |